Stoke Therapeutics, Inc.(STOK)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

STOK Stoke Therapeutics, Inc.

未开盘 05-08 16:00:00 EDT

11.60

-0.34

-2.85%

盘后11.60

+0.000.00%

19:10 EDT

最高12.12	最低11.38	成交量80.35万
今开11.72	昨收11.94	日振幅6.20%
总市值6.05亿	流通市值4.63亿	总股本5,212万
成交额932.99万	换手率2.01%	流通股本3,991万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"STOK","market":"US","secType":"STK","nameCN":"Stoke Therapeutics, Inc.","latestPrice":11.6,"timestamp":1715198400000,"preClose":11.94,"halted":0,"volume":803454,"hourTrading":{"tag":"盘后","latestPrice":11.6,"preClose":11.6,"latestTime":"19:10 EDT","volume":321743,"amount":3732236.2,"timestamp":1715209805763},"delay":0,"floatShares":39913602,"shares":52119860,"eps":-2.415895,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.34,"latestTime":"05-08 16:00:00 EDT","open":11.72,"high":12.12,"low":11.38,"amount":9329851.666266,"amplitude":0.061977,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.415895,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1715241600000},"adr":0,"listingDate":1560916800000,"adjPreClose":11.94,"preHourTrading":{"tag":"盘前","latestPrice":11.77,"preClose":11.94,"latestTime":"09:12 EDT","volume":3,"amount":35.31,"timestamp":1715173927297},"postHourTrading":{"tag":"盘后","latestPrice":11.6,"preClose":11.6,"latestTime":"19:10 EDT","volume":321743,"amount":3732236.2,"timestamp":1715209805763},"volumeRatio":1.146202},"requestUrl":"/m/hq/s/STOK","defaultTab":"news","newsList":[{"id":"2433786337","title":"加拿大投资银行集团：维持Stoke Therapeutics(STOK.US)评级，由买入调整至买入评级, 目标价由21.00美元调整至20.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2433786337","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2433786337?lang=zh_cn&edition=full","pubTime":"2024-05-07 22:25","pubTimestamp":1715091952,"startTime":"0","endTime":"0","summary":"加拿大投资银行集团：维持Stoke Therapeutics(STOK.US)评级，由买入调整至买入评级, 目标价由21.00美元调整至20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072225578ae54144&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405072225578ae54144&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432377875","title":"Stoke Therapeutics Inc   预计每股亏损61美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432377875","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432377875?lang=zh_cn&edition=full","pubTime":"2024-05-01 00:17","pubTimestamp":1714493843,"startTime":"0","endTime":"0","summary":"   * Stoke Therapeutics Inc    预计将在5月2日公布截至2024年3月31日的业绩(估计)，季度收入将出现下降。* 根据LSEG的数据，7位分析师的平均预期显示，这家总部位于马萨诸塞州贝德福德的公司的营收预计将从去年同期的515万美元下降37.6%，至321.4万美元。* LSEG 分析师对 Stoke Therapeutics Inc 的平均预期是每股亏损 61 美分。* 华尔街对 Stoke Therapeutics Inc 的 12 个月目标价中位数为 21.50 美元，高于其最新收盘价 11.86 美元。4月30日 - 以往季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2427833065","title":"Stoke Therapeutics, Inc.盘中异动 临近收盘股价大跌5.40%报12.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427833065","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427833065?lang=zh_cn&edition=full","pubTime":"2024-04-16 03:55","pubTimestamp":1713210950,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日03时55分，Stoke Therapeutics, Inc.股票出现异动，股价急速跳水5.40%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.54%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、安皮奥制药、Longeveron Inc.涨幅较大，Longeveron Inc.、Soligenix, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1740.30%、1265.91%、910.77%，振幅较大的相关个股有安皮奥制药、Soligenix, Inc.、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为273.33%、124.89%、80.04%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过基于RNA的药物上调蛋白质表达来解决严重疾病的潜在原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240416035550861e5e36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240416035550861e5e36&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426292785","title":"Stoke Therapeutics, Inc.盘中异动 股价大涨5.17%报13.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426292785","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426292785?lang=zh_cn&edition=full","pubTime":"2024-04-12 03:47","pubTimestamp":1712864869,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日03时47分，Stoke Therapeutics, Inc.股票出现波动，股价急速拉升5.17%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过基于RNA的药物上调蛋白质表达来解决严重疾病的潜在原因。该信息摘要如下：Needham：重申Stoke Therapeutics评级，由买入调整至买入评级, 目标价22.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404120347497a52322b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404120347497a52322b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426119830","title":"Stoke Therapeutics, Inc.盘中异动 股价大跌5.46%报12.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426119830","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426119830?lang=zh_cn&edition=full","pubTime":"2024-04-09 22:54","pubTimestamp":1712674447,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日22时54分，Stoke Therapeutics, Inc.股票出现波动，股价大幅下挫5.46%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，Acrivon Therapeutics, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Mymd Pharmaceuticals, Inc.、Biophytis、Acrivon Therapeutics, Inc.较为活跃，换手率分别为439.46%、104.03%、67.41%，振幅较大的相关个股有Biophytis、Mymd Pharmaceuticals, Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 ，振幅分别为39.96%、33.85%、23.31%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过基于RNA的药物上调蛋白质表达来解决严重疾病的潜在原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409225407791f6d4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409225407791f6d4f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425676385","title":"Stoke Therapeutics, Inc.盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425676385","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425676385?lang=zh_cn&edition=full","pubTime":"2024-04-05 23:20","pubTimestamp":1712330456,"startTime":"0","endTime":"0","summary":"北京时间2024年04月05日23时20分，Stoke Therapeutics, Inc.股票出现异动，股价快速拉升5.01%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.67%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过基于RNA的药物上调蛋白质表达来解决严重疾病的潜在原因。消息层面，截至23时20分，《Form 144 | Stoke Therapeutics高管拟出售9,426股股份，价值约12.73万美元》资讯为影响Stoke Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405232057861e390a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405232057861e390a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424397323","title":"Stoke Therapeutics, Inc.盘中异动 急速拉升5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424397323","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424397323?lang=zh_cn&edition=full","pubTime":"2024-04-04 21:41","pubTimestamp":1712238104,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日21时41分，Stoke Therapeutics, Inc.股票出现波动，股价大幅上涨5.19%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过基于RNA的药物上调蛋白质表达来解决严重疾病的潜在原因。消息层面，截至21时41分，《Form 144 | Stoke Therapeutics高管拟出售9,426股股份，价值约12.73万美元》资讯为影响Stoke Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404214144861e3677&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240404214144861e3677&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424093045","title":"Stoke Therapeutics, Inc.盘中异动 急速下挫5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424093045","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424093045?lang=zh_cn&edition=full","pubTime":"2024-04-02 21:31","pubTimestamp":1712064665,"startTime":"0","endTime":"0","summary":"北京时间2024年04月02日21时31分，Stoke Therapeutics, Inc.股票出现异动，股价急速下跌5.51%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.14%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过基于RNA的药物上调蛋白质表达来解决严重疾病的潜在原因。消息层面，截至21时31分，《Form 144 | Stoke Therapeutics高管拟出售9,426股股份，价值约12.73万美元》资讯为影响Stoke Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404022131067a50b5a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404022131067a50b5a4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422114919","title":"BUZZ-斯托克治疗公司股票发行上市后再次大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2422114919","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2422114919?lang=zh_cn&edition=full","pubTime":"2024-03-27 23:16","pubTimestamp":1711552580,"startTime":"0","endTime":"0","summary":"    3月27日 - ** Stoke Therapeutics  股价上涨45.8%，报15美元，创2022年11月以来新高，延续上一交易日的大涨势头** 在该公司宣布其癫痫治疗药物 STK-001 的早期数据  后，STOK 周二收盘上涨 58%，报 10.29 美元。 ** 周二收盘后，该公司宣布  发行 7,500 万美元股票，为候选产品的开发/生产提供资金，包括 STK-001 的后期开发** 摩根大通是此次发行的唯一簿记管理人，定于周三收市后定价** 根据 LSEG 数据，该公司拥有约 4,630 万股流通股，市值近 7 亿美元","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422661658","title":"BUZZ-Stoke Therapeutics 因癫痫药物早期数据良好而跃升","url":"https://stock-news.laohu8.com/highlight/detail?id=2422661658","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2422661658?lang=zh_cn&edition=full","pubTime":"2024-03-26 17:54","pubTimestamp":1711446861,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    3月26日 - ** 药物开发商Stoke Therapeutics的股价  盘前攀升69.7%至11.03美元 ** 该公司周一晚些时候宣布， (link)，其治疗一种癫痫的实验性药物的早期数据呈阳性，该 药物适用于2至18岁已服用抗癫痫药物的患者。     ** STOK 公司称，该药物有助于大幅减少癫痫发作，并改善认知和行为。** 公司称该药物的耐受性普遍良好** STOK 计划与监管机构会面，讨论注册研究计划，并在 2024 年晚些时候提供最新讨论情况** 截至上次收盘，股价已累计上涨 23.6","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422799415","title":"斯托克治疗公司（Stoke Therapeutics Inc）公布截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2422799415","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2422799415?lang=zh_cn&edition=full","pubTime":"2024-03-26 05:04","pubTimestamp":1711400650,"startTime":"0","endTime":"0","summary":"   * Stoke Therapeutics Inc   报告，截至12月底的季度调整后每股亏损60美分，高于去年同期的每股-65美分。九位分析师对该季度的平均预期是每股亏损 63 美分。华尔街预期为每股-71美分至-48美分。* 营收为 280 万美元，同比下降 14.3%；分析师预期为 325 万美元。* Stoke Therapeutics 公司公布的本季度每股收益为亏损 60 美分。* 该公司当季亏损2696万美元。* 本季度，Stoke Therapeutics Inc 的股价上涨了 19.8%。华尔街对 Stoke Therapeutics Inc 的 12 个月目标价中位数为 18.00 美元。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422548662","title":"Stoke Therapeutics, Inc.盘中异动 早盘快速上涨5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422548662","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422548662?lang=zh_cn&edition=full","pubTime":"2024-03-25 21:41","pubTimestamp":1711374079,"startTime":"0","endTime":"0","summary":"北京时间2024年03月25日21时41分，Stoke Therapeutics, Inc.股票出现异动，股价快速拉升5.40%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Landos Biopharma, Inc.、Altamira Therapeutics Ltd.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Altamira Therapeutics Ltd.、Salarius Pharmaceuticals, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1530.73%、53.64%、31.48%，振幅较大的相关个股有Altamira Therapeutics Ltd.、Xtl生物制药、Sagimet Biosciences Inc. - Series A，振幅分别为32.37%、19.84%、14.63%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过基于RNA的药物上调蛋白质表达来解决严重疾病的潜在原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403252141197a4ee86a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403252141197a4ee86a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421884396","title":"Stoke Therapeutics, Inc.盘中异动 快速上涨5.01%报6.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421884396","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421884396?lang=zh_cn&edition=full","pubTime":"2024-03-22 23:11","pubTimestamp":1711120280,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日23时11分，Stoke Therapeutics, Inc.股票出现波动，股价急速拉升5.01%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Effector Therapeutics Inc C/Wts 31/12/2025 、Outlook Therapeutics, Inc.涨幅较大，Outlook Therapeutics, Inc.、180 Life Sciences Corp.、安皮奥制药较为活跃，换手率分别为77.64%、35.47%、21.04%，振幅较大的相关个股有Matinas Biopharma Holdings, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Nutriband Inc C/Wts ，振幅分别为53.68%、43.92%、42.98%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过基于RNA的药物上调蛋白质表达来解决严重疾病的潜在原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032223112087e7b181&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032223112087e7b181&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421332774","title":"Stoke Therapeutics, Inc.盘中异动 下午盘股价大涨6.55%报6.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421332774","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421332774?lang=zh_cn&edition=full","pubTime":"2024-03-21 02:16","pubTimestamp":1710958600,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日02时16分，Stoke Therapeutics, Inc.股票出现波动，股价大幅上涨6.55%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.50%。其相关个股中，Xtl生物制药、Surrozen Inc C/Wts 01/08/2031 、Eiger Biopharmaceuticals, Inc.涨幅较大，Xtl生物制药、Jaguar Health, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为206.93%、86.05%、46.19%，振幅较大的相关个股有Xtl生物制药、Nls Pharmaceutics Ltd.、Igc Pharma, Inc.，振幅分别为157.69%、66.78%、43.55%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过基于RNA的药物上调蛋白质表达来解决严重疾病的潜在原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403210216407a4dfec3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403210216407a4dfec3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420606272","title":"Stoke Therapeutics, Inc.盘中异动 急速下跌5.10%报5.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420606272","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420606272?lang=zh_cn&edition=full","pubTime":"2024-03-19 23:45","pubTimestamp":1710863113,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日23时45分，Stoke Therapeutics, Inc.股票出现异动，股价快速跳水5.10%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，Fusion Pharmaceuticals Inc.、Moolec Science Sa C/Wts 、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大，Enveric Biosciences, Inc.、Hoth Therapeutics, Inc.、Scisparc Ltd.较为活跃，换手率分别为873.67%、419.61%、330.82%，振幅较大的相关个股有Enveric Biosciences, Inc.、Scisparc Ltd.、知临集团，振幅分别为67.27%、52.67%、49.87%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过基于RNA的药物上调蛋白质表达来解决严重疾病的潜在原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240319234513861df73f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240319234513861df73f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419981984","title":"Stoke Therapeutics, Inc.盘中异动 股价大跌5.11%报6.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419981984","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419981984?lang=zh_cn&edition=full","pubTime":"2024-03-15 00:05","pubTimestamp":1710432355,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日00时05分，Stoke Therapeutics, Inc.股票出现波动，股价急速下跌5.11%。Stoke Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.27%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、知临集团、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，知临集团、Novabay Pharmaceuticals, Inc.、Gri Bio, Inc.较为活跃，换手率分别为742.18%、172.92%、77.87%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、知临集团、Psyence Biomedical Ltd.，振幅分别为110.40%、76.91%、65.38%。Stoke Therapeutics, Inc.公司简介：Stoke Therapeutics Inc 致力于通过基于RNA的药物上调蛋白质表达来解决严重疾病的潜在原因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403150005557a4cbcb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403150005557a4cbcb4&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.stoketherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.1077},{"period":"3month","weight":1.6424},{"period":"6month","weight":1.723},{"period":"1year","weight":-0.0461},{"period":"ytd","weight":1.2053}],"compareEarnings":[{"period":"1week","weight":0.0337},{"period":"1month","weight":-0.0029},{"period":"3month","weight":0.0379},{"period":"6month","weight":0.1738},{"period":"1year","weight":0.2586},{"period":"ytd","weight":0.0881}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Stoke Therapeutics, Inc.成立于2014年6月，根据特拉华州法律注册成立。该公司是一家早期生物制药公司，通过精确上调蛋白质表达，开创了治疗严重遗传疾病根本原因的新方法。他们正在开发新的反义寡核苷酸，或ASO，针对核糖核酸或RNA，调节前体的药物-作用RNA或前mRNA，剪接以在需要时上调蛋白质表达并且具有接近正常水平的适当特异性。他们利用其专有技术平台，核基因输出的靶向增强或TANGO，设计ASO以通过患者中的个体基因上调蛋白质的表达。他们的方法旨在以高度精确，持久和受控的方式向广泛的相关组织（包括中枢神经系统或中枢神经系统，眼睛，肾脏和肝脏）提供疾病改善疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.047456},{"month":2,"riseRate":0.4,"avgChangeRate":0.077295},{"month":3,"riseRate":0.4,"avgChangeRate":0.066891},{"month":4,"riseRate":0.2,"avgChangeRate":-0.135958},{"month":5,"riseRate":0.8,"avgChangeRate":0.138658},{"month":6,"riseRate":0.25,"avgChangeRate":-0.062453},{"month":7,"riseRate":0.4,"avgChangeRate":-0.100682},{"month":8,"riseRate":0.6,"avgChangeRate":0.092897},{"month":9,"riseRate":0.2,"avgChangeRate":-0.152069},{"month":10,"riseRate":0.6,"avgChangeRate":0.097204},{"month":11,"riseRate":0.4,"avgChangeRate":-0.037094},{"month":12,"riseRate":0.8,"avgChangeRate":0.184055}],"exchange":"NASDAQ","name":"Stoke Therapeutics, Inc.","nameEN":"Stoke Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Stoke Therapeutics, Inc.(STOK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Stoke Therapeutics, Inc.(STOK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Stoke Therapeutics, Inc.,STOK,Stoke Therapeutics, Inc.股票,Stoke Therapeutics, Inc.股票老虎,Stoke Therapeutics, Inc.股票老虎国际,Stoke Therapeutics, Inc.行情,Stoke Therapeutics, Inc.股票行情,Stoke Therapeutics, Inc.股价,Stoke Therapeutics, Inc.股市,Stoke Therapeutics, Inc.股票价格,Stoke Therapeutics, Inc.股票交易,Stoke Therapeutics, Inc.股票购买,Stoke Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Stoke Therapeutics, Inc.(STOK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Stoke Therapeutics, Inc.(STOK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}